These results are supported by other studies which display a block in NK cell maturation in animal experimental models of AML, evidenced by their incapacity to pass from stage 2 (CD27+CD11b−) to stage 3 (CD27+CD11b+) NK cells in the spleen [31]. The gene discussed is ITGAM; the disease is acute myeloid leukemia.